This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zindy, F. Articles by Roussel, M. F. Search for Related Content PubMed PubMed Citation Articles by Zindy, F. Articles by Roussel, M. F.

Genetic Alterations in Mouse Medulloblastomas and Generation of Tumors De novo from Primary Cerebellar Granule Neuron Precursors

Departments of ¹ Genetics and Tumor Cell Biology, ² Developmental Neurobiology, and ³ Pathology and ⁴ Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, Tennessee

Requests for reprints: Martine F. Roussel, Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105. Phone: 901-495-3481; Fax: 901-495-2381; E-mail: martine.roussel{at}stjude.org.

Mice lacking p53 and one or two alleles of the cyclin D–dependent kinase inhibitor p18^Ink4c are prone to medulloblastoma development. The tumor frequency is increased by exposing postnatal animals to ionizing radiation at a time when their cerebella are developing. In irradiated mice engineered to express a floxed p53 allele and a Nestin-Cre transgene, tumor development can be restricted to the brain. Analysis of these animals indicated that inactivation of one or both Ink4c alleles did not affect the time of medulloblastoma onset but increased tumor invasiveness. All such tumors exhibited complete loss of function of the Patched 1 (Ptc1) gene encoding the receptor for sonic hedgehog, and many exhibited other recurrent genetic alterations, including trisomy of chromosome 6, amplification of N-Myc, modest increases in copy number of the Ccnd1 gene encoding cyclin D1, and other complex chromosomal rearrangements. In contrast, medulloblastomas arising in Ptc1^+/– mice lacking one or both Ink4c alleles retained p53 function and exhibited only limited genomic instability. Nonetheless, complete inactivation of the wild-type Ptc1 allele was a universal event, and trisomy of chromosome 6 was again frequent. The enforced expression of N-Myc or cyclin D1 in primary cerebellar granule neuron precursors isolated from Ink4c^–/–, p53^–/– mice enabled the cells to initiate medulloblastomas when injected back into the brains of immunocompromised recipient animals. These "engineered" tumors exhibited gene expression profiles indistinguishable from those of medulloblastomas that arose spontaneously. These results underscore the functional interplay between a network of specific genes that recurrently contribute to medulloblastoma formation. [Cancer Res 2007;67(6):2676–84]

This article has been cited by other articles:

				O. Ayrault, M. D. Godeny, C. Dillon, F. Zindy, P. Fitzgerald, M. F. Roussel, and H. M. Beere Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma PNAS, October 6, 2009; 106(40): 17037 - 17042. [Abstract] [Full Text] [PDF]

				T. Uziel, F. V. Karginov, S. Xie, J. S. Parker, Y.-D. Wang, A. Gajjar, L. He, D. Ellison, R. J. Gilbertson, G. Hannon, et al. The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma PNAS, February 24, 2009; 106(8): 2812 - 2817. [Abstract] [Full Text] [PDF]

				P.-O. Frappart, Y. Lee, H. R. Russell, N. Chalhoub, Y.-D. Wang, K. E. Orii, J. Zhao, N. Kondo, S. J. Baker, and P. J. McKinnon Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency PNAS, February 10, 2009; 106(6): 1880 - 1885. [Abstract] [Full Text] [PDF]

				R. Saab, C. Rodriguez-Galindo, K. Matmati, J. E. Rehg, S. H. Baumer, J. D. Khoury, C. Billups, G. Neale, K. J. Helton, and S. X. Skapek p18Ink4c and p53 Act as Tumor Suppressors in Cyclin D1-Driven Primitive Neuroectodermal Tumor Cancer Res., January 15, 2009; 69(2): 440 - 448. [Abstract] [Full Text] [PDF]

				J. D. Kessler, H. Hasegawa, S. N. Brun, B. A. Emmenegger, Z.-J. Yang, J. W. Dutton, F. Wang, and R. J. Wechsler-Reya N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma Genes & Dev., January 15, 2009; 23(2): 157 - 170. [Abstract] [Full Text] [PDF]

				O. Ayrault, F. Zindy, J. Rehg, C. J. Sherr, and M. F. Roussel Two Tumor Suppressors, p27Kip1 and Patched-1, Collaborate to Prevent Medulloblastoma Mol. Cancer Res., January 1, 2009; 7(1): 33 - 40. [Abstract] [Full Text] [PDF]

				M. Tanori, M. Mancuso, E. Pasquali, S. Leonardi, S. Rebessi, V. Di Majo, M.-N. Guilly, F. Giangaspero, V. Covelli, S. Pazzaglia, et al. PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma Carcinogenesis, October 1, 2008; 29(10): 1911 - 1919. [Abstract] [Full Text] [PDF]

				K. M. Reilly, J. B. Rubin, R. J. Gilbertson, J. R. Garbow, M. F. Roussel, and D. H. Gutmann Rethinking Brain Tumors: The Fourth Mouse Models of Human Cancers Consortium Nervous System Tumors Workshop Cancer Res., July 15, 2008; 68(14): 5508 - 5511. [Full Text] [PDF]

				H. Zhao, O. Ayrault, F. Zindy, J.-H. Kim, and M. F. Roussel Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development Genes & Dev., March 15, 2008; 22(6): 722 - 727. [Abstract] [Full Text] [PDF]